Financial News

Bayer reaches US$2 billion deal over future Roundup cancer claims

Bayer AG struck a US$2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday.

Exit mobile version
Skip to toolbar